Key result
Azithromycin for the treatment of bronchiolitis obliterans syndrome in adult lung transplant recipients is described in this study protocol, which does not report any clinical findings.
Key points are not available for this paper at this time.
Protocol for azithromycin in post-transplant BOS published without data; leaves open macrolide efficacy pending trial completion.
Azithromycin for treatment of bronchiolitis obliterans syndrome in adult lung transplant recipients (Protocol)
No takes yet. Share an insight, caveat, or question.
Safavi et al. (2017) studied this question. Azithromycin for the treatment of bronchiolitis obliterans syndrome in adult lung transplant recipients is described in this study protocol, which does not report any clinical findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: